Novel Synthetic Biomaterials for Kidney-Derived Progenitor / Stem Cell Differentiation

I Hopp
End-stage kidney disease is increasing in prevalence and is associated with high levels of morbidity and mortality. At present, the only treatment options are dialysis or renal transplantation. However, dialysis is very costly and is associated with high levels of morbidity, whereas the problem with transplantation is that there is a shortage of organ donors. For these reasons, over recent years, there has been an increasing interest in developing novel therapies in the field of...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.